| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |